Its a pill-based medication that mimics the GLP1 hormone to help regulate blood sugar, promote weight loss, and reduce heart disease risk
The medication is typically taken once daily, with or without food, and is available in strengths such as 5 mg and 10 mg
J Endocrinol 219:5968 Mieczkowska A, Mansur S, Bouvard B, Flatt PR, Thorens B, Irwin N, Chappard D, Mabilleau G (2015) Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength
Semaglutide has a black box warning from the FDA (U.S
The observational study is managed by Columbia University and its participants include more than two dozen research sites around the country, such as Jefferson Medical College in Philadelphia